Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Medicines (Basel, Switzerland)|October 24, 2025
Checklist-Based Identification of Adverse Drug Reactions in Emergency Department PatientsBenjamin J Hellinger, Thilo Bertsche, Yvonne Remane, et al.
Journal of Health Politics, Policy and Law|January 6, 2001
Community control and pricing patterns of nonprofit hospitals: An antitrust analysisG J Young, K R Desai, F J Hellinger
Die Anaesthesiologie|November 17, 2023
[Adverse drug reactions as cause of nonspecific symptoms in patients in the emergency department]Benjamin J Hellinger, Yvonne Remane, Thilo Bertsche, et al.
British Journal of Clinical Pharmacology|March 1, 1996
Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomesU Christians, G Schmidt, A Bader, et al.
Clinical Biochemistry|June 1, 1991
Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparationsU Christians, H H Radeke, R Kownatzki, et al.
Bone Marrow Transplantation|July 1, 1993
Cyclosporine metabolite pattern in blood from patients with acute GVHD after BMTU Christians, K Spiekermann, A Bader, et al.
Therapeutic Drug Monitoring|October 1, 1995
Parallel blood concentrations of second-generation cyclosporine metabolites and bilirubin in liver graft recipientsU Christians, K Kohlhaw, T Sürig, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|August 31, 2023
A prospective intervention study to identify drug-related emergency department visits comparing a standard care group and a pharmaceutical care groupBenjamin J Hellinger, André Gries, Susanne Schiek, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1991
Investigations on the metabolic pathways of cyclosporine: II. Elucidation of the metabolic pathways in vitro by human liver microsomesU Christians, S Strohmeyer, R Kownatzki, et al.
Pageof 9